Carlos Mena-Hurtado, MD
Cardiovascular Disease · New Haven, CTNPI 1205800273
Payments from drug & device makers
Across 406 payments — averaging $1638.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$118K
- Abbott$69K
- Shockwave Medical, Inc$62K
- Cardiva Medical, Inc.$58K
- Surmodics, Inc.$47K
- Medtronic$44K
- plus $268K from 21 others
Across 5 payments — averaging $3664.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Philips North America LLC$18K
What the payments were for
- Consulting fees$238,53852%
- Speaking & faculty fees$171,59037%
- Travel & lodging$42,3789%
- Food & beverage$7,6552%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 31 | $117,789 |
| Abbott | 62 | $69,279 |
| Shockwave Medical, Inc | 41 | $62,250 |
| Cardiva Medical, Inc. | 3 | $57,619 |
| Surmodics, Inc. | 68 | $46,976 |
| Medtronic(2 entities) | 47 | $43,607 |
| Cook Research Incorporated | 1 | $37,500 |
| Novo Nordisk | 1 | $36,110 |
| Cardinal Health 200 LLC | 24 | $32,665 |
| Boston Scientific | 17 | $27,119 |
| Bolton Medical Inc | 2 | $25,000 |
| Bard Peripheral Vascular, Inc. | 11 | $23,343 |
| Cook Medical LLC | 42 | $17,285 |
| Penumbra, Inc. | 16 | $16,952 |
| W. L. Gore & Associates, Inc. | 9 | $13,923 |
| Contego Medical, Inc | 6 | $9,303 |
| M.a. Med Alliance S.A. | 4 | $6,581 |
| Endologix LLC | 9 | $6,300 |
| Cordis Corporation | 1 | $5,850 |
| Veryan Medical Incorporated | 3 | $4,142 |
| Trireme Medical LLC | 2 | $3,250 |
| Heartflow, Inc. | 1 | $2,000 |
| Philips North America LLC | 1 | $125 |
| Ablative Solutions, Inc. | 1 | $95 |
| Cordis US CORP. | 1 | $62 |
| Siemens Medical Solutions USA, Inc. | 1 | $30 |
| Cardiovascular Systems Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cook Medical Zilver PTX$62,960
- Emboshield NAV6 system$40,341
- Cook Medical IAA$37,229
- Saxenda$36,110
- IN.PACT Admiral$35,812
- Zilver PTX$26,020
- TREO ABDOMINAL STENT-GRAFT SYSTEM$25,000
- Omnilink Elite vascular stent system$19,750
- Indigo$9,673
- MYNX CONTROLTM$9,451
- GORE VIABAHN VBX Balloon Expandable Endo$8,580
- GORE VIABAHN Endoprosthesis$8,580
- GORE VIABAHN Endoprosthesis with Heparin$8,580
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$8,580
- Indigo System$7,999
- ELUVIA$7,000
- Mynx Ace Vascular Closure Device$5,750
- EluNIR Radaforolimus Eluting Coronary Stent System$5,650
- Resolute$4,785
- RAILWAYTM$4,500
How this compares
$665,161 in reported general payments places this provider in the 95th percentile of 415 cardiovascular disease providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 19 | $23,600 |
| EliquisApixaban | 23 | $20,972 |
| BrilintaTicagrelor | 13 | $12,862 |
| Praluent PenAlirocumab | 15 | $8,276 |
| ClopidogrelClopidogrel Bisulfate | 112 | $1,303 |
| Cilostazol | 16 | $577 |
| Atorvastatin Calcium | 56 | $550 |
| Rosuvastatin Calcium | 40 | $497 |
| Ezetimibe | 18 | $338 |
| Carvedilol | 15 | $202 |
| Metoprolol Succinate | 25 | $195 |
| Losartan Potassium | 29 | $195 |
| Furosemide | 40 | $136 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $133 |
| Lisinopril | 23 | $111 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in New Haven
- Harlan KrumholzNew Haven$4M
- Jeffery TestaniNew Haven$3.4M
- Nihar DesaiNew Haven$3.2M
- John ForrestNew Haven$1.2M
- Hyung ChunNew Haven$1.1M
- Rohan KheraNew Haven$930K
- John StendahlNew Haven$419K
- Tariq AhmadNew Haven$317K
- Rachel LampertNew Haven$310K
- Daniel JacobyNew Haven$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.